CVS stock news · CVS Health
Get alerts for CVS
Follow CVS Health (CVS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CVSCVS Health and Aetna opened the Phoenix Residential project in Milwaukee, offering 21 affordable homes for families.
NeutralCVS Health and Aetna celebrated the opening of a Milwaukee housing project they helped fund in 2024. It supports local families but reports no change to CVS's business.
CVS Pharmacy gives families advice on getting ready for cold and flu season.
NeutralCVS shared seasonal health tips and pointed shoppers to its products and pharmacist services. The story reports no sales or customer response, so it does not change CVS's outlook.
Amaresh Siva is leaving CVS Health to work at Alaska Airlines.
NeutralCVS Health executive Amaresh Siva left for Alaska Airlines, where he will be its technology chief. The report names no change to CVS's services or plans, so its outlook is unchanged.
CVS will pay $315 million to settle claims about giving out opioids illegally.
Bad for CVSCVS Health agreed to pay $315 million and take on added federal oversight. The payment and ongoing duties make this unfavorable for its pharmacy business, despite closing the claims.
UnitedHealth says 2026 will be the worst year for its Medicaid profits.
NeutralCVS's Aetna plans will tighten Medicare Advantage networks by 2027 as medical and drug bills rise. The report gives no result showing whether the changes will lower costs or hurt enrollment.
Aetna, part of CVS Health, says high Medicare Star Ratings make them feel good about getting back to healthy profits.
Good for CVSCVS said over 69% of Aetna’s Medicare Advantage members are in 2027 plans rated 4 stars or higher. That supports Aetna’s margin-recovery effort, though recovery has not been reported.
12 health care companies saw big changes in their stock prices after the market closed on Thursday.
NeutralThe article reports that CVS Health shares fell 4% after hours. It gives no business reason or company update, so the report does not change the company's outlook.
The $90 Medicare payment is small, but older people have a big impact on the economy.
NeutralThe article says retirees spend heavily on medical care, but gives no new figures for CVS or healthcare use. Medical and living costs may also keep older households cautious.
Robert Kennedy Jr. wants new rules for healthcare prices, and HHS says patients need to see costs clearly.
NeutralCVS must follow new pricing rules, including added reporting and phone support. The story gives no estimate of their cost or effect on its sales or profit, so its outlook is unchanged.
Here are 3 health care stocks that could jump up in September.
NeutralCVS had an Aetna policy change and a low RSI noted by the article. Those facts pull opposite directions and leave the company reading unchanged.
Trump's choice for Surgeon General has investments in tobacco and soda companies while Kennedy fights against sugary drinks and junk food.
NeutralCVS Health (CVS): The nominee disclosed a CVS holding and agreed to divest it if confirmed. That planned sale does not change CVS's business fundamentals.
Mark Cuban's drug pricing strategy gains support from Bill Ackman: Potential winners and losers among healthcare stocks emerge.
Bad for CVSGreater PBM transparency and a shift toward cash/Cost-Plus distribution could pressure CVS's traditional PBM-related economics tied to negotiating rebates and spread pricing.
Senator Elizabeth Warren asserts that a small group of CEOs controls the decisions of Americans, emphasizing the necessity to prevent large-scale mergers.
Bad for CVSSenator Elizabeth Warren criticized corporate consolidation and urged regulators to block mega-mergers, highlighting CVS and UnitedHealth as examples of vertical integration in healthcare. She emphasized the influence of a few powerful companies on consumer choices and supported legislation aimed at increasing competition in the healthcare sector.
Walmart reaches a $50 million settlement with the DOJ concerning alleged violations of opioid prescription regulations, labeling the payment as ‘immaterial’.
NeutralArticle notes CVS reached larger prior settlements, signaling industry liability, but provides no fresh CVS-specific news to warrant a directional change.
CVS Health Corp outlines changes in leadership with the exit and election of directors, along with the appointment of new officers and their compensation arrangements.
NeutralCVS Health Corporation has filed a Form 8-K detailing the departure and appointment of certain directors and officers, which could lead to shifts in the company's governance and strategic initiatives. Such changes are critical for investors to monitor as they may influence CVS's future performance and market perception.
New agreement with Eli Lilly aims to enhance affordable access to GLP-1 medications for CVS.
NeutralCVS Health's strong second-quarter earnings and raised guidance have led to a bullish outlook for the company, despite a slight pullback in stock price due to profit-taking. The new partnership with Eli Lilly to improve access to GLP-1 medications further enhances CVS's market position and could drive additional revenue growth.